In a new study, researchers detected high concentrations of these drugs and their metabolised remnants in the brain tissue of 10 fish species found in the Niagara River.
This vital conduit connects two of the Great Lakes, Lake Erie and Lake Ontario, via Niagara Falls.
The discovery of antidepressants in aquatic life in the river raises serious environmental concerns, said Diana Aga, from the University at Buffalo in the US.
"These active ingredients from antidepressants, which are coming out from wastewater treatment plants, are accumulating in fish brains," Aga said.
"Other research teams have shown that antidepressants can affect the feeding behavior of fish or their survival instincts. Some fish won't acknowledge the presence of predators as much," she added.
If changes like these occur in the wild, they have the potential to disrupt the delicate balance between species that helps to keep the ecosystem stable, said Randolph Singh, a recent graduate from Aga's lab.
"The levels of antidepressants found do not pose a danger to humans who eat the fish, especially in the US, where most people do not eat organs like the brain," Singh said.
The study looked for a variety of pharmaceutical and personal care product chemicals in the organs and muscles of 10 fish species: smallmouth bass, largemouth bass, rudd, rock bass, white bass, white perch, walleye, bowfin, steelhead and yellow perch.
Antidepressants stood out as a major problem. These drugs or their metabolites were found in the brains of every fish species the scientists studied.
The highest concentration of a single compound was found in a rock bass, which had about 400 nanogrammes of norsertraline - a metabolite of sertraline, the active ingredient in Zoloft - per gramme of brain tissue.
More than half of the fish brain samples had norsertraline levels of 100 nanogrammes per gramme or higher.
In addition, like the rock bass, many of the fish had a medley of antidepressant drugs and metabolites in their brains.
The research was published in the journal Environmental Science and Technology.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
